Talis Biomedical Corp Annual Depreciation in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Talis Biomedical Corp annual/quarterly Depreciation history and growth rate from 2020 to 2022.
  • Talis Biomedical Corp Depreciation for the quarter ending September 30, 2022 was $3.3M.
  • Talis Biomedical Corp annual Depreciation for 2022 was $6.6M, a 313% increase from 2021.
  • Talis Biomedical Corp annual Depreciation for 2021 was $1.6M, a 100% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6.6M +$5M +313% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-22
2021 $1.6M +$800K +100% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 $800K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.